88IV - Public company info - Zylox-Tonbridge Medical Technology Co. Ltd. -H Shares

Input the stock code or the company name

Zylox-Tonbridge Medical Technology Co. Ltd. -H Shares, 02190.HK - Cash Flow	2021-12	2020-12	2019-12
Net Cash Flow from Operating Activities	-127,533	-82,694	-53,181
Net Cash Flow from Return on Investments & Servicing of Finance	11,020	-306	-946
Interest Received	11,327	360	89
Interest Paid	-307	-666	-1,035
Dividend Received	0	0	0
Dividend Paid	0	0	0
Others	0	0	0
Taxes (Paid) / Refunded	0	0	0
Net Cash Flow from Investing Activities	-1,328,351	-249,176	-90,593
Additions to Fixed Assets	-89,595	-45,140	-41,582
Disposal of Fixed Assets	109	41	22
Increase in Investments	-1,504,697	-489,200	-466,000
Decrease in Investments	1,665,832	285,123	416,967
Net Cash Flow with Related Parties	513,574	336,376	180,000
Others	-1,913,574	-336,376	-180,000
Net Cash Flow before Financing Activities	-1,444,864	-332,176	-144,720
Net Cash Flow from Financing Activities	2,810,130	346,203	180,479
New Loans	5,000	35,500	17,500
Loans Repayment	-39,198	-25,673	-17,021
Fixed Income/Debt Instruments	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0
Equity Financing	2,454,660	0	0
Net Cash Flow with Related Parties	513,574	336,376	180,000
Others	-123,906	0	0
Increase(Decrease) in Cash & Cash Equivalents	1,365,266	14,027	35,759
Cash & Cash Equivalents at Beginning of Year	59,556	46,130	10,480
Net Cash Flow due to Change in Exchange Rate/Others	-6,463	-601	-109
Cash & Cash Equivalents at End of Year	1,418,359	59,556	46,130
Currency	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Zylox-Tonbridge Medical Technology Co. Ltd. -H Shares , 02190.HK